38P Impact of 1-year COVID-19 pandemic in patients with ovarian carcinoma treated with chemotherapy based on a global data network
L.M. Manso Sànchez(Hospital Universitario 12 De Octubre), L. Paz-Ares(Hospital Universitario 12 De Octubre), L. Lema Roso(Hospital Universitario 12 De Octubre), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), A. Madariaga Urrutia(Hospital Universitario 12 De Octubre), Pablo Serrano Balazote(Office for National Statistics), A. Modrego(Hospital Universitario 12 De Octubre), Gema Hernández(Universidad Politécnica de Madrid), P. Tolosa Ortega(Hospital Universitario 12 De Octubre), Manuel Alva(Hospital Universitario 12 De Octubre)
Cited by 0
Related Papers
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
|British Journal of Cancer|2017|106
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
|JAMA Oncology|2024|77
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
|Nature Communications|2023|65
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
|European Journal of Surgical Oncology|2018|60
Chronic opioid therapy in long-term cancer survivors
|Clinical & Translational Oncology|2016|59